187 related articles for article (PubMed ID: 30477410)
21. Key production parameters for the development of solid lipid nanoparticles by high shear homogenization.
Souto EB; Doktorovova S; Zielinska A; Silva AM
Pharm Dev Technol; 2019 Nov; 24(9):1181-1185. PubMed ID: 31354002
[TBL] [Abstract][Full Text] [Related]
22. Solid lipid nanoparticles for hydrophilic biotech drugs: optimization and cell viability studies (Caco-2 & HEPG-2 cell lines).
Severino P; Andreani T; Jäger A; Chaud MV; Santana MH; Silva AM; Souto EB
Eur J Med Chem; 2014 Jun; 81():28-34. PubMed ID: 24819957
[TBL] [Abstract][Full Text] [Related]
23. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
[TBL] [Abstract][Full Text] [Related]
24. Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method.
Pereira I; Zielińska A; Ferreira NR; Silva AM; Souto EB
Int J Pharm; 2018 Oct; 549(1-2):261-270. PubMed ID: 30075252
[TBL] [Abstract][Full Text] [Related]
25. Solid lipid nanoparticles for delivery of Calendula officinalis extract.
Arana L; Salado C; Vega S; Aizpurua-Olaizola O; Arada I; Suarez T; Usobiaga A; Arrondo JLR; Alonso A; Goñi FM; Alkorta I
Colloids Surf B Biointerfaces; 2015 Nov; 135():18-26. PubMed ID: 26231862
[TBL] [Abstract][Full Text] [Related]
26. Solid lipid nanoparticles optimized by 2
Rigon RB; Gonçalez ML; Severino P; Alves DA; Santana MHA; Souto EB; Chorilli M
Colloids Surf B Biointerfaces; 2018 Nov; 171():501-505. PubMed ID: 30081382
[TBL] [Abstract][Full Text] [Related]
27. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.
Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L
Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944
[TBL] [Abstract][Full Text] [Related]
28. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
Aji Alex MR; Chacko AJ; Jose S; Souto EB
Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
[TBL] [Abstract][Full Text] [Related]
29. Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology.
Pandey S; Patel P; Gupta A
Curr Pharm Des; 2018; 24(16):1811-1820. PubMed ID: 29788881
[TBL] [Abstract][Full Text] [Related]
30. Controlled SLN Delivery by Thermoresponsive In-situ Forming Erodible Gels; A Whole-body and Organ Imaging Study.
Dorraj G; Dadashzadeh S; Erfan M; Moghimi HR
Curr Drug Deliv; 2018; 15(4):510-519. PubMed ID: 29422000
[TBL] [Abstract][Full Text] [Related]
31. Insights into the protective role of solid lipid nanoparticles on rosmarinic acid bioactivity during exposure to simulated gastrointestinal conditions.
Madureira AR; Campos DA; Oliveira A; Sarmento B; Pintado MM; Gomes AM
Colloids Surf B Biointerfaces; 2016 Mar; 139():277-84. PubMed ID: 26766625
[TBL] [Abstract][Full Text] [Related]
32. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
33. Study of solid lipid nanoparticles with respect to particle size distribution and drug loading.
Patravale VB; Ambarkhane AV
Pharmazie; 2003 Jun; 58(6):392-5. PubMed ID: 12857001
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
Wang F; Li L; Liu B; Chen Z; Li C
Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
[TBL] [Abstract][Full Text] [Related]
35. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
Baek JS; Cho CW
Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles (PLX-SLN): Characterization of physicochemical properties and in vitro efficacy.
Severino P; Silveira EF; Loureiro K; Chaud MV; Antonini D; Lancellotti M; Sarmento VH; da Silva CF; Santana MHA; Souto EB
Eur J Pharm Sci; 2017 Aug; 106():177-184. PubMed ID: 28576561
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of solid lipid nanoparticles containing peptide.
Hu FQ; Hong Y; Yuan H
Int J Pharm; 2004 Apr; 273(1-2):29-35. PubMed ID: 15010127
[TBL] [Abstract][Full Text] [Related]
38. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
39. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model.
Shi LL; Cao Y; Zhu XY; Cui JH; Cao QR
Int J Pharm; 2015 Jan; 478(1):60-69. PubMed ID: 25448568
[TBL] [Abstract][Full Text] [Related]
40. Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).
Heider M; Hause G; Mäder K
Eur J Pharm Biopharm; 2016 Dec; 109():194-205. PubMed ID: 27789354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
